SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-326762
Filing Date
2021-11-12
Accepted
2021-11-12 06:04:33
Documents
15
Period of Report
2021-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d260908d8k.htm   iXBRL 8-K 25425
2 EX-99.1 d260908dex991.htm EX-99.1 128980
3 EX-99.2 d260908dex992.htm EX-99.2 42605
7 GRAPHIC g260908g1112020203361.jpg GRAPHIC 2283
  Complete submission text file 0001193125-21-326762.txt   351826

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20211111.xsd EX-101.SCH 2904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20211111_lab.xml EX-101.LAB 18123
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20211111_pre.xml EX-101.PRE 11413
8 EXTRACTED XBRL INSTANCE DOCUMENT d260908d8k_htm.xml XML 3346
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 211398893
SIC: 2835 In Vitro & In Vivo Diagnostic Substances